Clinical Hematology International
Volume 3, Issue 2, June 2021
Mini Review
1. How to Make the Right Diagnosis in Neutropenia
Elena E. Solomou, Christina Salamaliki, Maria Lagadinou
Pages: 41 - 46
Isolated neutropenia without anemia or thrombocytopenia is a common clinical problem. The etiology of neutropenia may vary from transient bone marrow suppression, caused by self-limited viral illnesses, to previously undiagnosed congenital syndromes or serious systemic diseases. Consequently, determining...
Review Article
2. Passive Immunity Should and Will Work for COVID-19 for Some Patients
Nevio Cimolai
Pages: 47 - 68
In the absence of effective antiviral chemotherapy and still in the context of emerging vaccines for severe acute respiratory syndrome-CoV-2 infections, passive immunotherapy remains a key treatment and possible prevention strategy. What might initially be conceived as a simplified donor–recipient process,...
Perspective
3. Red Blood Cell Distribution Width: Another Prognostic Factor for COVID-19?
Maria Lagadinou, Despoina Gkentzi, Markos N. Marangos, Fotini Paliogianni, Elena E. Solomou
Pages: 69 - 71
The coronavirus disease 2019 (COVID-19) is a pandemic with a high rate of hospitalization, admission to intensive care units, and mortality. Identifying patients at the highest risk for severe disease is important to facilitate early, aggressive intervention. High red blood cell distribution width (RDW)...
Research Article
4. Allogeneic Stem Cell Transplantation with a Novel Reduced Intensity Conditioning Regimen for the Treatment of Patients with Primary Cutaneous T-cell Lymphomas
Maria Stamouli, Konstantinos Gkirkas, Aggeliki Karagiannidi, Theodoros Iliakis, Spiros Chondropoulos, Thomas Thomopoulos, Vassiliki Nikolaou, Vassiliki Pappa, Evangelia Papadavid, Panagiotis Tsirigotis
Pages: 72 - 76
The prognosis of patients with mycosis fungoides (MF) and Sezary Syndrome (SS) varies greatly, from near normal life expectancy in patients with early stage, to a median survival of less than 2 years for those diagnosed with advanced stage disease. Initial response to treatment is almost always followed...